Welcome to our dedicated page for NORTHROP GRUMMAN /DE/ SEC filings (Ticker: NOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NORTHROP GRUMMAN /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NORTHROP GRUMMAN /DE/'s regulatory disclosures and financial reporting.
Capital International Investors, a division of Capital Research and Management Company and its affiliated investment management entities, reported beneficial ownership of 6,044,489 shares of Northrop Grumman Corp. common stock. This represents 4.3% of the 142,033,476 shares believed to be outstanding as of the report.
Capital International Investors has sole voting power over 5,851,522 shares and sole dispositive power over 6,044,489 shares, with no shared voting or dispositive power. The filing indicates ownership of 5 percent or less of this class of securities.
Northrop Grumman Corp. director Mark A III Welsh reported selling a total of 95 shares of common stock on August 3, 2026. The 10 open‑market transactions were executed at weighted‑average prices including $544.53 and $554.14 per share, pursuant to a pre‑arranged Rule 10b5‑1 trading plan adopted on August 23, 2025.
A shareholder of Northrop Grumman Corp. filed to sell common stock on or after 07/22/2026 through Merrill Lynch on the NYSE. The planned sale covers multiple blocks of common stock originally received as equity compensation from grants dated between 2015 and 2026, including an entry for 4,304 units tied to a May 20, 2026 grant.
Northrop Grumman reported Q2 2026 sales of $10.9 billion, up 5% year over year, with net earnings of $1.09 billion and diluted EPS of $7.68, down 6% mainly because 2025 included a $231 million gain on the sale of its training services business and a larger pension FAS/CAS adjustment.
For the first six months, sales rose 5% to $20.8 billion, net earnings grew 19% to $2.0 billion, and diluted EPS increased 21% to $13.83, helped by stronger segment operating income and a sharply lower effective tax rate of 10.4% versus 17.5%, driven by research tax credits and remeasurement of uncertain tax positions.
Aeronautics led growth, with sales up 15% year to date and operating income rebounding as prior‑year B‑21 loss charges did not recur, though the B‑21 LRIP phase still carries about $2.0 billion in cumulative losses and a $1.0 billion remaining loss accrual. Defense Systems grew sales organically but margins compressed on unfavorable cost estimate changes for missile programs, including SiAW. Mission Systems expanded margins above 15%, while Space Systems margins were pressured by cost growth on solid rocket motor work.
Backlog reached $104.7 billion, with 35% expected to convert to revenue within 12 months. Operating cash flow was a use of $376 million year to date as working capital increased, while the company invested $469 million in capital expenditures, paid $684 million in dividends after a 7% per‑share increase, repurchased $68 million of stock and reduced long‑term debt by $527 million.
Northrop Grumman reported solid top-line growth in second quarter 2026 while earnings softened year-over-year. Sales rose 5 percent to $10.9 billion, driven by increases across all four segments, led by 13 percent growth at Aeronautics Systems. Net earnings were $1.1 billion and diluted EPS were $7.68, down 7 percent and 6 percent, respectively, largely because the prior-year period included a $231 million gain from the divestiture of the training services business. Net awards reached $20.0 billion, lifting total backlog to a record $104.7 billion.
Operating income declined 23 percent to $1.1 billion and the operating margin fell to 10.1 percent, reflecting the absence of the prior divestiture gain and lower segment operating income, particularly at Defense Systems and Space Systems, where unfavorable EAC adjustments on missile and space programs weighed on margins. Cash generation improved meaningfully: net cash provided by operating activities increased 47 percent to $1,280 million and adjusted free cash flow rose 54 percent to $978 million. On the back of stronger demand and record backlog, the company raised its 2026 sales guidance to $43.75–$44.25 billion and MTM-adjusted EPS guidance to $28.60–$29.10, while reaffirming operating income and adjusted free cash flow targets.
Brown Marianne Catherine reported acquisition or exercise transactions in this Form 4 filing.
Northrop Grumman director Marianne Catherine Brown received an award of 91 shares of common stock, valued at $509.31 per share, as a compensation grant. The shares were deferred into a stock unit account under the company’s 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3. After this award, she holds 11,558 shares of common stock, including dividends, in the stock unit account pursuant to the plan, reflecting a routine, non–open-market equity compensation event.
KRISHNA ARVIND reported acquisition or exercise transactions in this Form 4 filing.
Northrop Grumman director Arvind Krishna received 71 shares of common stock, valued at $509.31 per share, as a grant under the company’s 2024 Long-Term Incentive Stock Plan. The award was deferred into a stock unit account and is exempt under Rule 16b-3, bringing his directly held and deferred stock units to 2,749 shares.
Northrop Grumman Corporation reported the final voting results from its 2026 Annual Meeting of Shareholders. Shareholders elected eleven directors to the board, including Chair and CEO Kathy J. Warden and ten other nominees, each receiving a substantial majority of votes cast in favor.
On an advisory basis, shareholders approved the compensation of the company’s named executive officers, with 107,398,463 votes for, 5,220,362 against and 851,475 abstentions. Shareholders also ratified Deloitte & Touche LLP as independent auditor for the fiscal year ending December 31, 2026, with 121,265,768 votes for, 5,116,361 against and 373,605 abstentions.
A shareholder proposal to require an independent board chair did not pass, receiving 23,610,695 votes for and 88,773,053 against, with 1,086,552 abstentions. The board stated it will carefully consider shareholder input and feedback received through engagement.
Northrop Grumman director Mary A. Winston reported a compensation-related stock award rather than an open-market trade. She received 349 shares of common stock on May 20, 2026 as a grant or award at $552.17 per share, with the shares deferred into a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3. After this acquisition, she directly holds 1,609 shares of common stock and indirectly holds 9 shares in an IRA. A footnote explains that her total amount also includes 78 shares of common stock and 1,540 shares of common stock equivalents, including dividends, held in stock unit accounts under current and prior long-term incentive plans.
WELSH MARK A III reported acquisition or exercise transactions in this Form 4 filing.
Northrop Grumman director Mark A. Welsh III received a grant of 349 shares of common stock on May 20, 2026. The award was priced at $552.17 per share and was deferred into a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3.
After this award, he beneficially holds 4,470 shares and stock units in total, including 488 shares of common stock and 3,982 shares of common stock equivalents, including dividends, in stock unit accounts under the company’s long-term incentive plans.